TECHNOLOGY LICENSING OPPORTUNITY: NanoFET
AI Overview
Technology licensing opportunity for NanoFET immunotherapy platform from LANL: modular, self-assembling peptide nanofiber scaffold for rapid development of targeted therapeutics and medical countermeasures.
This summary is AI-generated from the official solicitation.
Key Details
Official Description
NanoFiber Engineered Therapeutics Platform (NanoFET) from Los Alamos National Laboratory offers pharmaceutical and biodefense organizations a modular, adaptable scaffold for building next-generation immunotherapies. By merging self-assembling peptide nanofibers with interchangeable nanobody and peptide components, the platform enables rapid development of targeted treatments that bridge disease agents directly to the patient’s own immune cells. Infectious diseases and chronic conditions such as ...
Change History
TECHNOLOGY LICENSING OPPORTUNITY: NanoFET
New SAM.gov opportunity: TECHNOLOGY LICENSING OPPORTUNITY: NanoFET
Similar Opportunities
Get Alerts for Opportunities Like This
RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.
Start Free Trial